This test is most useful if any of these apply to you.
A single morning urine sample contains hundreds of small molecules your body has discarded after running its biochemistry overnight. The Organic Acids Test (OAT) reads dozens of those molecules at once and uses the pattern to ask a different question than blood testing usually asks: not what is circulating right now, but what is leaving the system, and why.
This panel is exploratory rather than a routine adult screen. It was developed inside functional medicine to surface patterns in cellular energy production, gut microbial activity, neurotransmitter turnover, and detoxification demand that standard bloodwork is not designed to see. Standardized cutoffs and outcome studies for general preventive use are still limited, so results are best read as hypotheses to investigate, not diagnoses.
The clinical story this panel tells covers several distinct domains at once. Each domain is read by a small cluster of markers, and the value of doing them together is that the clusters cross-check each other. The American College of Medical Genetics and Genomics (ACMG) treats organic acid analysis as a first-tier laboratory test for inborn errors of metabolism, and the same chemistry underlies the broader functional read offered by this panel.
Inside every cell, a chain of reactions called the Krebs cycle (also known as the citric acid cycle) burns fuel into the molecule that powers everything you do. When that chain gets backed up, intermediates spill into urine in characteristic patterns. The panel measures most of the cycle's main intermediates along with lactic and pyruvic acids, the upstream feeders that accumulate when oxygen-dependent metabolism is sluggish. A study of pediatric primary mitochondrial disease found increased urinary cis-aconitate, fumarate, and succinate compared to controls. Backlogs at specific steps can point to nutrient cofactor shortages, mitochondrial inefficiency, or impaired energy production.
Bacteria and yeast leave behind chemicals that humans do not make, and many of them pass straight into urine. The panel reads several of these. One group reflects beneficial bacterial activity and microbiome diversity. Hippuric acid, for example, has been associated with greater gut microbial diversity and consumption of polyphenol-rich foods including coffee, whole grains, and fruit, and with lower odds of metabolic syndrome. Another group is read as overgrowth signals: HPHPA (3-(3-hydroxyphenyl)-3-hydroxypropionic acid) and 4-cresol are reported alongside Clostridia activity, arabinose alongside Candida fermentation, and several furan and tartrate compounds alongside fungal byproducts. The panel cannot identify which species are present, but it can show whether the chemistry of microbial output looks balanced.
The panel measures urinary breakdown products of dopamine, norepinephrine, and serotonin, plus two compounds from the tryptophan-to-NAD (nicotinamide adenine dinucleotide, a key energy molecule) pathway that rise during neuroinflammation. Urine values do not directly mirror brain levels, but elevations and depressions can track high-volume turnover or shifted balance. In a systematic review of human studies, urinary quinolinic acid rose during acute physiological stress and in several chronic inflammatory conditions. The catecholamine metabolites homovanillic acid (HVA) and vanillylmandelic acid (VMA) are also used clinically to screen for catecholamine-producing tumors in children. That diagnostic use is separate from how the markers are read inside this panel.
When fat oxidation runs cleanly, only small amounts of the intermediate dicarboxylic acids should appear in urine. Elevations of adipic, suberic, and sebacic acids are sensitive but nonspecific signals of impaired mitochondrial beta-oxidation of fatty acids. The panel also reports the two main ketones the body makes when it shifts toward fat fuel. Alongside these, several markers reflect the working demand on individual B vitamins. Methylmalonic acid in urine is one of the earliest and most specific signals of cellular vitamin B12 deficiency, with the urine-to-creatinine ratio limiting the effect of kidney function on the value. Pyridoxic acid covers B6, pantothenic acid covers B5, and glutaric acid covers riboflavin and lysine handling.
Pyroglutamic acid, also called 5-oxoproline, rises when the body is recycling glutathione under high demand and glycine availability falls behind. Pyroglutamic acidosis from blocked glutathione regeneration has been documented in patients with septic shock. 2-Hydroxybutyric acid, orotic acid, and the salicylate-related markers complete the read on cleanup throughput. A urinary creatinine value is reported alongside everything else so each result can be normalized to how dilute or concentrated the sample is.
No single marker on this panel is diagnostic on its own. The interpretation rule is to look for clusters that agree. A scattered elevation on one marker with everything else normal is usually background variation. A cluster of elevations within one domain is what the panel is built to find.
| Pattern | What It Suggests |
|---|---|
| Elevated arabinose, citramalic, and tartaric acids | Yeast or fungal fermentation pattern; warrants further gut workup before assuming Candida overgrowth |
| Elevated HPHPA, 4-cresol, and 4-hydroxyphenylacetic acid | Clostridia-associated microbial pattern; consider stool testing to confirm |
| Elevated Krebs cycle intermediates with high lactic and pyruvic acid | Cellular energy bottleneck or B-vitamin cofactor shortage; check B1, B2, B3, and coenzyme Q10 (CoQ10) status |
| Elevated methylmalonic acid with normal serum vitamin B12 | Functional B12 deficiency at the cellular level despite a normal blood number |
The decision pathway depends on which domain lit up. A microbial pattern is worth pairing with a stool test before any antimicrobial or antifungal treatment, because urine chemistry alone cannot prove which organism is responsible. A mitochondrial or Krebs cycle pattern is worth pairing with serum B vitamins, homocysteine, and a measure of insulin resistance, since cofactor deficiencies and metabolic disease both push the same intermediates upward. A functional B12 signal from urinary methylmalonic acid is worth confirming with serum vitamin B12 and homocysteine before starting supplementation.
For neurotransmitter and neuroinflammation markers, the most useful next step is usually clinical: a structured review of sleep, mood, stress load, and any medications that affect catecholamine or serotonin handling, rather than treatment aimed at the urinary number itself. For fatty acid oxidation markers, a fasting state at collection alone can produce the same elevations as a real defect, so a clean repeat under non-fasting conditions is the cheapest next move.
Retesting cadence depends on what you change. After a meaningful intervention (antimicrobial protocol, targeted nutrient repletion, change in fueling strategy), a repeat at three to six months is the shortest interval that will show a real shift. Without an intervention, annual retesting is reasonable for tracking and pattern recognition.
Urine concentration drives everything on this panel. A dehydrated morning sample will push most analytes upward, and a very dilute sample will pull them down. The creatinine value on the report is the correction factor, but extreme values on either end make the whole panel harder to read.
Diet in the 24 hours before collection matters. Foods rich in benzoates, polyphenols, or salicylates shift hippurate and related microbial markers. Bananas, walnuts, pineapple, tomatoes, and avocados can falsely raise 5-hydroxyindoleacetic acid (5-HIAA), the serotonin metabolite. L-dopa medications can falsely raise HVA and VMA. A fasting collection inflates ketones and dicarboxylic acids, while a recent course of antibiotics or antifungals can flatten the gut microbial section for weeks afterward.
OAT is best interpreted alongside these tests.